PEDRON, Serena
 Distribuzione geografica
Continente #
NA - Nord America 3.622
EU - Europa 3.554
AS - Asia 2.295
SA - Sud America 272
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 88
OC - Oceania 4
Totale 9.984
Nazione #
US - Stati Uniti d'America 3.509
RU - Federazione Russa 1.354
SG - Singapore 850
GB - Regno Unito 694
CN - Cina 685
IT - Italia 465
HK - Hong Kong 232
VN - Vietnam 215
SE - Svezia 209
BR - Brasile 204
DE - Germania 198
FR - Francia 144
IE - Irlanda 140
FI - Finlandia 130
KR - Corea 69
CA - Canada 63
BD - Bangladesh 50
ES - Italia 47
NL - Olanda 36
IN - India 35
UA - Ucraina 35
AR - Argentina 33
JP - Giappone 30
BE - Belgio 29
MX - Messico 29
TR - Turchia 27
NG - Nigeria 21
ID - Indonesia 17
PL - Polonia 16
IQ - Iraq 15
ZA - Sudafrica 13
BJ - Benin 12
EC - Ecuador 11
AT - Austria 10
EG - Egitto 10
PH - Filippine 8
TG - Togo 7
VE - Venezuela 7
CO - Colombia 6
KG - Kirghizistan 6
LT - Lituania 6
SA - Arabia Saudita 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
HR - Croazia 5
IL - Israele 5
JM - Giamaica 5
PK - Pakistan 5
PT - Portogallo 5
TN - Tunisia 5
UZ - Uzbekistan 5
AU - Australia 4
HN - Honduras 4
IR - Iran 4
KE - Kenya 4
MY - Malesia 4
PY - Paraguay 4
RS - Serbia 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
GR - Grecia 3
LB - Libano 3
MA - Marocco 3
NP - Nepal 3
AM - Armenia 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CL - Cile 2
CM - Camerun 2
ET - Etiopia 2
GY - Guiana 2
KZ - Kazakistan 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BB - Barbados 1
BZ - Belize 1
GA - Gabon 1
IM - Isola di Man 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MG - Madagascar 1
MK - Macedonia 1
NI - Nicaragua 1
SC - Seychelles 1
TM - Turkmenistan 1
Totale 9.838
Città #
Southend 579
Moscow 511
Singapore 458
Ashburn 421
Dallas 371
Chandler 328
San Jose 322
Hong Kong 225
Verona 174
Jacksonville 158
Ann Arbor 151
Council Bluffs 148
Beijing 143
Dublin 138
Woodbridge 133
New York 101
Houston 93
The Dalles 87
Los Angeles 78
Munich 66
Ho Chi Minh City 58
Hanoi 54
Helsinki 48
Wilmington 47
Jinan 45
Princeton 45
Lawrence 44
Nanjing 41
Shenyang 38
Madrid 37
Orem 34
Redmond 34
Buffalo 33
Tianjin 32
Santa Clara 31
Brussels 29
Milan 28
Turku 28
London 26
Tokyo 26
Columbus 24
Montreal 23
Redondo Beach 22
Sindelfingen 21
São Paulo 21
Abuja 20
Guangzhou 19
Phoenix 19
Seoul 19
Zhengzhou 19
Dearborn 17
Hebei 17
Ningbo 17
Toronto 17
Amsterdam 15
Changsha 15
Haikou 15
Hangzhou 15
Mexico City 15
San Francisco 15
Atlanta 14
Chennai 14
Lancaster 14
Nanchang 13
Rome 13
Taizhou 13
Cotonou 12
Düsseldorf 12
Seattle 12
Warsaw 12
Denver 11
Poplar 11
Stockholm 11
Boardman 10
Bologna 10
Chicago 10
Frankfurt am Main 10
Jakarta 10
Johannesburg 10
Redwood City 10
Brescia 9
Dong Ket 9
Florence 9
Jiaxing 9
Fairfield 8
Nuremberg 8
Biên Hòa 7
Brooklyn 7
Da Nang 7
Kyiv 7
Lomé 7
Naples 7
Querétaro 7
Rio de Janeiro 7
Washington 7
Cairo 6
Chions 6
Haiphong 6
Hải Dương 6
Taiyuan 6
Totale 6.185
Nome #
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 320
Genomic characterization of hepatoid tumors: context matters 261
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 250
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 247
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 246
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 244
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 225
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 218
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 216
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 214
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 202
Linfoma splenico a "cellule della zona marginale": studio dell'espressione di TCL1 e t-bet 198
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 197
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 195
CATHEPSIN-K IS A SENSITIVE IMMUNOHISTOCHEMICAL MARKER FOR DETECTION OF MICRO-GRANULOMAS IN HYPERSENSITIVITY PNEUMONITIS 194
S100P expression in cholangiocarcinoma 192
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 192
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 192
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 189
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 189
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 187
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 182
The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study 179
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 179
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 178
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 177
ANALISI DEL DNA MEDIANTE FLUORESCENT IN SITU HYBRIDIZATION (FISH) PER L’IDENTIFICAZIONE DI ERRORI DI SCAMBIO DI TESSUTI DOPO PROCEDURE CHIRURGICHE: APPLICAZIONI NELLA PRATICA CLINICA ED IMPLICAZIONI MEDICO LEGALI 174
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 173
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 171
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 170
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 170
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 165
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 165
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 161
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 161
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 152
Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications 150
The Immunohistochemical Loss of H3K27me3 in Intracranial Meningiomas Predicts Shorter Progression-Free Survival after Stereotactic Radiosurgery 150
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 147
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 143
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 137
TCL1 and CD11c expression in hairy-cell leukemia and their diagnostic role on bone marrow biopsies in the differential diagnosis with splenic marginal zone lymphoma 136
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology 135
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 133
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 131
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 130
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 122
Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk 121
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 118
Neurotoxic effects of rotenone and deltamethrin prolonged exposure on adult zebrafish 111
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 108
High performance of multiplex fluorescence in situ hybridization to simultaneous detection of BCL2 and BCL6 rearrangements: useful application in the characterization of DLBCLs 108
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 101
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 96
Refining prognostic stratification of atypical meningiomas: significance of chromosome 1p deletion and brain invasion 94
SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation 93
Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism 92
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 91
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations 83
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 58
Stimulator of interferon genes immunohistochemical expression in the spectrum of extrarenal perivascular epithelioid cell lesions 25
Prognostic stratification of chordoid meningiomas: the role of chromosome 1p/22q Loss 19
Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor 12
Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma 10
Nectin-4 and Trop-2 expression in collecting duct carcinoma: new promising therapeutic targets 5
Totale 9.984
Categoria #
all - tutte 32.912
article - articoli 28.312
book - libri 0
conference - conferenze 4.600
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022452 0 125 26 58 30 18 12 33 16 16 30 88
2022/2023931 58 115 85 161 77 224 7 50 103 8 28 15
2023/2024513 24 37 40 59 76 102 16 23 4 34 83 15
2024/20251.349 58 72 85 193 52 47 60 43 227 88 167 257
2025/20264.645 266 269 389 800 1.155 302 373 212 363 278 132 106
2026/2027173 79 94 0 0 0 0 0 0 0 0 0 0
Totale 9.984